Korea Institute of Science and Technology

University of Ulsan Foundation for Industry Cooperation

Industry Academic Cooperation Foundation Hallym University

Chu Won Nho

Jin Chul Kim

Eun Ha Lee

Jung Yeob Ham

Dorjsembe Banzragch

Sung Chul Hong

Young Tae Park

Myung Suk Kim

Hee Ju Lee

Kyung Su Kang

Saet Byoul Lee

Jin Soo Park

Sang Rok Oh

Hak Cheol Kwon

Tae Jung Kim

Cheol-Ho Pan

Jae Hee Jung

Seung Bok Lee

Gwi Nam Bae

Bo Mi Kwon

Gi Byoung Hwang

Jaeyoung Kwon

Byung Hun Um

Kil Choo Moon

Hyuk-Jai Jang

Hwa-Mi Lee

Na Ra Jeon

Ji Hye Yoo

Chang Ho Jhin

Suk Woo Kang

Yoon Shin Cho

Batsuren Dulamjav

Seong-Su Kim

Yeongseon Ahn

Tunsag Jigjidsuren

Ji-Hye Yoo

Cheon Soo Park

Dulamjav Batsuren

Da Hye Ryu

Ho Youn Kim

Seung Hoon Yang

Jai Eok Park

Disclosed is a composition for ameliorating, preventing or treating an autoimmune skin disease, containing a super pink (L.) extract as an active ingredient.

Composition for ameliorating psoriasis symptoms containing extract ofL

Disclosed is a composition for ameliorating, preventing or treating an autoimmune skin disease, containing a Musan box () extract or a fraction thereof as an active ingredient.

Composition for ameliorating psoriasis symptoms containing extract of

Disclosed is a composition for ameliorating, preventing or treating an autoimmune skin disease, containing a(steph) extract or a fraction thereof as an active ingredient.

Provided are a composition includingextract for treating wound, a method of treating wound of a subject, a cosmetic composition for wound improving, skin wrinkle improving, or skin anti-aging, and a method of cosmeticizing for wound improving, skin wrinkle improving, or skin anti-aging.

Composition for wound treatment containing extract ofor fraction thereof and method for treating wound of subject

Provided are a pharmaceutical composition including aextract as an active ingredient; and a method for preventing or treating ischemia-reperfusion injury in a subject by using a food composition or the pharmaceutical composition.

Composition comprisingextract for preventing or treating ischemia-reperfusion injury and use thereof

Provided are a method for preventing or treating obesity by using a composition including an inhibitor of expression of the Hoga1 gene or an inhibitor of activity of the Hoga1 protein as an active ingredient, and a method of screening a preventive or therapeutic agent for obesity by using the composition.

Method for preventing or treating obesity by using a composition including HOGA1-inhibiting substance and method of screening a preventive or therapeutic agent for obesity by using the composition

The present disclosure relates to an apparatus and a method for fabricating an antimicrobial hybrid material of a natural antimicrobial particle and a carbon nanomaterial, capable of fully utilizing the antimicrobial property of a natural antimicrobial material and a carbon nanomaterial by maximizing adsorption of the natural antimicrobial material on the carbon nanomaterial.

Apparatus and method for fabricating antimicrobial hybrid materials of natural product and carbon nanomaterials

The present invention relates to a method for the prevention and treatment of postmenopausal syndrome containing the step of administering a pharmaceutically effective dose of theor its fractions to a subject. The present inventors confirmed that theextract or its fractions of the invention prepared by using water, alcohol or a mixed solvent thereof could promote the expression of the promoter containing estrogen responsive element (ERE) and accelerated the growth of MCF-7, the human breast tissue originated cell line, suggesting that they had estrogen activity. The inventors further confirmed that the extract or its fractions of the invention had the effect of promoting osteocyte differentiation, so that they could be effectively used for the prevention and treatment of postmenopausal syndrome such as hot flush, osteoporosis and phlebothrombosis caused by estrogen deficiency.

[object Object]

The present invention relates to a pharmaceutical composition for the prevention and treatment of cancer comprising daurinol as an active ingredient, more precisely a pharmaceutical composition for the prevention and treatment of cancer comprising daurinol isolated from the medicinal plant of Mongolia,or, as an active ingredient. Daurinol can selectively block the S phase of cancer cell cycle to disturb the cycle and induce apoptosis stepwise, resulting in anticancer effect. Therefore, daurinol of the present invention can be used as a positive control chemical in the research and development field of cancer biology especially for cancer therapy and prevention. Daurinol also can be a promising candidate for a novel cell cycle blocker and a novel apoptosis inducer which could be effectively used for the prevention and treatment of cancer in the end.

Pharmaceutical composition containing daurinol for the prevention and treatment of cancers

Growing community of inventors

Gangneung-si, South Korea

Chu Won Nho